Policy Wisdom, LLC
Policy Wisdom, LLC is a global public health policy consulting firm founded in 2010, dedicated to delivering evidence-based solutions that positively impact public health worldwide. With a mission to be a benchmark of excellence in health policy, Policy Wisdom partners with governments, NGOs, pharmaceutical companies, and advocacy groups in over 150 countries. The company leverages a 100% virtual business model and a diverse, expert team to provide innovative methodologies and client-centered strategies. Their work spans policy strategy development, capacity building, evidence generation, and the creation of educational resources, all aimed at measurable improvements in health systems and equitable health outcomes. Policy Wisdom is recognized for its leadership in decolonizing global health, advancing precision medicine, and shaping policies that address both emerging and persistent public health challenges across the globe.
What We Do
A series of children's books designed to inspire the next generation of public health professionals and teach the importance and impact of health policies. Each book covers different aspects of public health, such as water safety, recycling, vaccines, nutrition, mental health, and more. Authored by Ana Rita González and team, available in print and Kindle formats, with profits supporting Global Health NOW.
Comprehensive policy landscape assessments, desired state and gap analysis, stakeholder mapping, network analysis, decision-making analysis, process mapping, key learnings assessment, policy market research, policy relevant archetypes, innovation adoption, strategic recommendations, policy planning workshops, strategic policy plans, war games and scenario planning, outcome tracking, policy impact evaluation, and engagement roadmaps.
Facilitation of policy advisory boards, policy roundtables, patient advisory boards, expert panel discussions, and policy speakers bureaus to gather insights and recommendations on specific policy issues.
Tailor-made policy and advocacy training, policy coaching, policy monitoring reports, and development of policy key performance indicators (PKPIs) to enhance public health policy awareness and effectiveness.
Production of white papers, consensus statements, policy briefs, peer-reviewed publications, fact sheets, infographics, argument dossiers, policy case studies, dissemination strategies, calls to action, policy scorecards, and policy narratives to support evidence-based policy making.
Psychological and Cognitive Health and Performance
Vaccines
Digital Health Technologies
Show More (8)Key People
President & CEO
Chief Operating Officer
Global Executive Director
News & Updates
Awarded for innovative methodologies, client-centered approach, and measurable impact on health systems worldwide.
Recognized for unwavering excellence and commitment to impactful public health policy consulting.
Named for expanding impactful public health policies worldwide and supporting clients' bottom lines.
Ana Rita González, President & CEO, recognized as a disruptive leader in global public policy.
Awarded for global impact in public health policy and projects spanning six continents and 152 countries.
This study examines how levels of democracy influence the quality of national cancer control plans across 40 countries. Findings show that more democratic systems produce more comprehensive, equitable, and evidence-based cancer policies, highlighting democracy as a key determinant of health.
Explores how recent geopolitical shifts, such as the U.S. withdrawal from the WHO and donor funding cuts, are reshaping the global health landscape. The article discusses the emergence of fragmented multilateralism, regional health architectures, and the need for adaptive governance to safeguard global health.
Recent Geopolitical Shifts and Their Implications for Global Health: A New World Order in The Making
Analyzes the shift from multilateralism to nationalism and its impact on global health governance and systems, presenting future scenarios and recommendations for strengthening health equity and resilience.
Explores the role of comprehensive policy frameworks in supporting precision medicine for cancer care in Latin America, identifying barriers, opportunities, and recommendations for equitable access and improved outcomes.
Discusses the adoption of precision medicine as the standard of care in cancer treatment, focusing on patient-driven recommendations, barriers to access, and the need for biomarker testing in emerging economies.
Presents evidence on the value of biomarker testing and precision medicine in Latin America, emphasizing the need for policies that promote equitable access to cancer treatment.
Introduces the Breast Cancer Care Quality Index (BCCQI), a global framework to improve breast cancer outcomes by addressing disparities in care and providing practical guidance for national cancer programs.
Highlights the importance of vaccination against respiratory diseases throughout all life stages in the Americas, addressing challenges such as low vaccine confidence, limited access, and proposing strategies for equitable vaccine access.
Provides a clear overview of current lung cancer policies in LATAM, identifying necessary changes for timely and adequate diagnosis and treatment.
Delivers a comprehensive analysis of colorectal cancer policies in LATAM, supporting the identification of policy improvements for better patient outcomes.
Provides a clear picture of the current policy situation for prostate cancer in LATAM, enabling identification of needed changes for timely and appropriate access to diagnosis and treatment.
Offers an assessment of multiple myeloma policy landscapes in Argentina and Brazil, highlighting gaps and opportunities for improved access to care.
Summarizes evidence and provides recommendations to improve access to rare disease diagnosis and treatment globally, addressing challenges faced by patients and stakeholders.
Examines the role and value of POC rapid testing for ARIs in a post-pandemic scenario, with recommendations for implementation in Latin America.
Explores the role of serology testing in COVID-19 immunization policies in the Asia-Pacific region, providing recommendations for policy inclusion and implementation.
Summarizes expert recommendations from roundtables on enabling innovation in healthcare systems and policies to improve public health outcomes.
Discusses the importance of digital health strategies and policy environments that support access to quality healthcare, with insights from global experts.
Explores the strategic evolution of the Medical Affairs function in the pharmaceutical sector and its growing role in policy-shaping and public health.
Examines the need to decolonize global health practices, offering methodologies and strategies for equitable, bi-directional partnerships in research and policy, especially in low- and middle-income countries.
Analyzes how multilateral guidance on mental health is incorporated into national health plans globally, with a focus on chronic and complex mental health conditions.
A bilingual platform for scientific exchange and education among public health specialists, focusing on HIV, syphilis, and Hepatitis. The summit addressed triple elimination of mother-to-child transmission, 4th-generation testing, and blood-based HIV self-testing, with outcomes including collaborative partnerships and strategic priorities for the Central and West Africa region.
Ana Rita Gonzalez, CEO of Policy Wisdom, participated in a panel on equitable access and improved health outcomes for all at the Concordia Annual Summit 2023 in NYC.